AI assistant
Sending…
BALCHEM CORP — Director's Dealing 2019
Feb 19, 2019
31041_dirs_2019-02-19_89352542-1a19-4792-a369-c41ddd0b0af6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: BALCHEM CORP (BCPC)
CIK: 0000009326
Period of Report: 2019-02-13
Reporting Person: MASON SCOTT C (N/A)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 214 | Direct |
| Common Stock | 8474 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $74.57 | 2028-02-23 | Common Stock (4700) | Direct | |
| Employee Stock Option (right to buy) | $84.09 | 2029-02-15 | Common Stock (5000) | Direct |
Footnotes
F1: Ownership consists of 214 shares held in Reporting Person's Company 401(k)/profit sharing plan account.
F2: Ownership of restricted stock vests in Reporting Person 3 years following the grant dates and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.
F3: Options vest 20% year 1; 40% year 2; and 40% year 3
More from BALCHEM CORP
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Major Shareholding Notification
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 27
Proxy Solicitation & Information Statement
2026
Apr 27
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Feb 20
Regulatory Filings
2026
Feb 20
Regulatory Filings
2026
Feb 19